Scribd Logo
Upload

Welcome to Scribd!

  • 37 views

    Fibrinolysis Inhibitors: Antihemorrhagi C

    Uploaded by

    Denise Louise Po
    C.S., a 52-year-old female, was admitted to the OB ward for excessive vaginal bleeding. She was prescribed tranexamic acid to be taken orally every 8 hours to treat her abnormal uterine bleeding by competitively inhibiting the activation of plasminogen and reducing the conversion of plasminogen to plasmin, which degrades fibrin clots. Nursing considerations for the patient included monitoring her vital signs and for overt bleeding, instructing her to take the full tablet as prescribed and notify nurses if bleeding recurs, and cautioning her to make slow position changes to avoid hypotension.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Fibrinolysis Inhibitors: Antihemorrhagi C

    Uploaded by

    Denise Louise Po
    37 views2 pages
    C.S., a 52-year-old female, was admitted to the OB ward for excessive vaginal bleeding. She was prescribed tranexamic acid to be taken orally every 8 hours to treat her abnormal uterine bleeding by competitively inhibiting the activation of plasminogen and reducing the conversion of plasminogen to plasmin, which degrades fibrin clots. Nursing considerations for the patient included monitoring her vital signs and for overt bleeding, instructing her to take the full tablet as prescribed and notify nurses if bleeding recurs, and cautioning her to make slow position changes to avoid hypotension.

    Original Description:

    Tranexamic Acid used for patients with conditions like bleeding, no clotting factor, or etc..

    Original Title

    Tranexamic Acid

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    C.S., a 52-year-old female, was admitted to the OB ward for excessive vaginal bleeding. She was prescribed tranexamic acid to be taken orally every 8 hours to treat her abnormal uterine bleeding by competitively inhibiting the activation of plasminogen and reducing the conversion of plasminogen to plasmin, which degrades fibrin clots. Nursing considerations for the patient included monitoring her vital signs and for overt bleeding, instructing her to take the full tablet as prescribed and notify nurses if bleeding recurs, and cautioning her to make slow position changes to avoid hypotension.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    37 views2 pages

    Fibrinolysis Inhibitors: Antihemorrhagi C

    Uploaded by

    Denise Louise Po
    C.S., a 52-year-old female, was admitted to the OB ward for excessive vaginal bleeding. She was prescribed tranexamic acid to be taken orally every 8 hours to treat her abnormal uterine bleeding by competitively inhibiting the activation of plasminogen and reducing the conversion of plasminogen to plasmin, which degrades fibrin clots. Nursing considerations for the patient included monitoring her vital signs and for overt bleeding, instructing her to take the full tablet as prescribed and notify nurses if bleeding recurs, and cautioning her to make slow position changes to avoid hypotension.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 2

    Patients Initials: C.S Age: 52 y.

    o Ward: OB- Prepartum


    Date of Admission: January 31, 2017 Attending Physician: Dr. M CC: Excessive vaginal bleeding
    Generic Name Brand Name Classification Mechanism of Indication Adverse Effects Nursing
    Action Considerations
    tranexamic acid Pharmacological; Treatment BEFORE:
    Tranexamic acid of abnormal
    Dosage: 500 mg/ uterine 1)Monitor VS as
    I tab fibrinolysis competitively
    bleeding indicated by
    Route: PO inhibitors inhibits
    severity of
    Frequency: activation of
    bleeding.
    Q8h (12n-8am- plasminogen
    4pm) thereby reducing
    Therapeutical; 2)Monitor for overt
    antihemorrhagi conversion of bleeding every 15
    c plasminogen to 30 min.
    plasmin 3)Assess for
    (fibrinolysin), an thromboembolic
    enzyme that complications.
    DURING:
    degrades fibrin
    4)Caution paient to
    clots, fibrinogen, take the whole
    and other tablet- not to crush
    plasma proteins, or half it.
    including the AFTER:
    procoagulant
    factors V and 5)Instruct patient to
    notify the nurse
    VIII. immediately if
    bleeding recurs

    6)Caution patient to
    make position
    changes slowly to
    avoid orthostatic
    hypotension.

    You might also like